OneMedNet initiates new Subscription Revenue model in partnership with Circle CVI

Rhea-AI Summary

OneMedNet (NASDAQ:ONMD) has established a strategic partnership with Circle Cardiovascular Imaging (Circle CVI) to implement a new subscription revenue model. Circle CVI will utilize OneMedNet's iRWD™ platform to access de-identified cardiovascular imaging data from over 1,750 provider sites, encompassing 131 million exams.

The partnership enables Circle CVI to leverage OneMedNet's extensive real-world data network for AI model development, cardiac diagnostics, and treatment planning. Data delivery is expected within 30 days, marking a shift from one-time transactions to a continuous subscription-based collaboration focused on advancing cardiovascular healthcare innovation.

Insights

Healthcare Technology Analyst

OneMedNet's new subscription revenue model with Circle CVI signals recurring revenue growth and stronger positioning in the healthcare AI data market.

OneMedNet's strategic partnership with Circle CVI marks a significant business model evolution toward recurring subscription revenue, representing a potential step-change in revenue predictability and growth trajectory. This isn't merely a one-off data sale but a sustained commercial relationship providing Circle CVI ongoing access to OneMedNet's vast repository of 131 million cardiovascular imaging exams from over 1,750 provider sites.

The partnership's structure is particularly noteworthy from a business perspective. By transitioning to a subscription model, OneMedNet potentially secures more predictable cash flow while Circle CVI gains continuous access to regulatory-grade data essential for AI model development in cardiovascular imaging. The relationship appears to have evolved from an initial transaction to a long-term commitment based on data quality performance.

What's most compelling is how this partnership positions OneMedNet in the rapidly growing healthcare AI data market. As regulatory scrutiny of AI applications in healthcare intensifies, access to diverse, high-quality, properly de-identified real-world data becomes increasingly valuable. OneMedNet's emphasis on "regulatory-grade" data suggests their platform meets the stringent requirements needed for AI model validation in clinical settings.

The announcement that data delivery will occur within 30 days indicates near-term revenue recognition, though specific financial terms remain undisclosed. For investors, this partnership demonstrates both market validation of OneMedNet's data quality and potential for an expanding subscription revenue base if the company can replicate this model with other healthcare technology partners.

MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced a long-term strategic partnership with Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in advanced cardiovascular imaging solutions. The collaboration reflects Circle CVI’s commitment to leveraging trusted, high-quality data to drive innovation in cardiac diagnostics, treatment planning, and AI model development with data being delivered in the next 30 days.

Circle CVI selected OneMedNet’s iRWD™ platform to access diverse and regulatory-grade imaging, ECG, and other cardiovascular datasets that align with the stringent requirements of healthcare AI innovation. By partnering with OneMedNet, Circle CVI gains secure, de-identified access to a growing network of real-world cardiovascular imaging data from over 1,750 provider sites — spanning over 131 million exams critical to developing, validating, and improving advanced cardiovascular solutions.

“Our initial experience with OneMedNet was exceptional — the quality, depth, and regulatory readiness of the data exceeded our expectations. It quickly became clear that this wasn’t just a one-time transaction, but the beginning of a long-term collaboration. That’s why we made the decision to partner with OneMedNet and move forward with a subscription — so we can continually access the high-quality, Real-World imaging data we trust to power our innovation,” said Erkan Akyuz, CEO of Circle CVI.

This strategic collaboration enables Circle CVI to expand its research and development capabilities while ensuring alignment with evolving regulatory and clinical evidence standards. It also exemplifies a growing industry shift toward real-world evidence as a foundation for medical innovation.

“We’re thrilled to enter into this long-term, collaborative relationship with Circle CVI,” said Aaron Green, President and CEO of OneMedNet. “This partnership is a testament to the quality of our Real-World Data — trusted by leading healthcare companies to accelerate innovation, by meeting the precise customer requirements for longitudinal clinical data with the ultimate goal of improving patient outcomes.”

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data — it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities — rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

About Circle Cardiovascular Imaging

Circle Cardiovascular Imaging (Circle CVI) is a Canadian-based company that was founded in 2007, established with the aim of developing innovative software solutions to enhance cardiovascular and cerebrovascular imaging analysis and improve patient care. Circle CVI's imaging platform provides best-in-class image reading and reporting for quantitative and qualitative assessment of cardiac MR, cardiac CT, vascular CT, and neuro CT.

At the heart of Circle CVI’s operations is a relentless commitment to providing improved solutions for healthcare providers, ultimately driving better healthcare outcomes. This commitment fuels the company’s creativity, guides its decision making, and underpins its passion for innovation.

Annually, millions of medical imaging exams — in over 1700 hospitals and in more than 90 countries — are estimated to be interpreted using cvi42. For additional information, please visit www.circlecvi.com or contact: marketing@circlecvi.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What is the new partnership between OneMedNet (ONMD) and Circle CVI?

OneMedNet and Circle CVI have formed a strategic partnership where Circle CVI will subscribe to OneMedNet's iRWD™ platform to access cardiovascular imaging data from over 1,750 provider sites for AI development and clinical innovation.

How many healthcare provider sites are included in OneMedNet's (ONMD) data network?

OneMedNet's network includes over 1,750 provider sites, providing access to more than 131 million exams of cardiovascular imaging data.

When will Circle CVI begin receiving data from OneMedNet (ONMD)?

Circle CVI will begin receiving data from OneMedNet within 30 days of the partnership announcement on August 18, 2025.

What type of revenue model is OneMedNet (ONMD) implementing with Circle CVI?

OneMedNet is implementing a subscription-based revenue model with Circle CVI, moving away from one-time transactions to establish a long-term collaborative relationship.

How will Circle CVI use OneMedNet's (ONMD) data?

Circle CVI will use OneMedNet's data for developing, validating, and improving advanced cardiovascular solutions, including AI model development, cardiac diagnostics, and treatment planning.